Fecal immunological blood test is more appealing than the guaiac-based test for colorectal cancer screening

被引:11
作者
Le Pimpec, Fanny [1 ]
Moutel, Gregoire [2 ,3 ]
Piette, Christine [4 ]
Lievre, Astrid [5 ,6 ,7 ]
Bretagne, Jean-Francois [4 ,5 ,6 ,7 ]
机构
[1] Univ Rennes 1, Fac Med, Dept Med Gen, Rennes, France
[2] Normandie Univ, Unicaen, INSERM, Canc & Prevent,U1086, Caen, France
[3] CHU Caen, Caen, France
[4] Assoc Depistage Canc Ille & Vilaine ADECI 35, Rennes, France
[5] CHU Rennes, Serv Malad Appareil Digestif, F-35033 Rennes, France
[6] Univ Rennes 1, Rennes, France
[7] Univ Rennes 1, Inserm Oncogenesis Stress & Signaling ER440, Rennes, France
关键词
Barriers and facilitators; Colorectal cancer screening; Fecal occult blood test; Fecal immunological testing; TEST FOBT; PROGRAM; PARTICIPATION; PRACTITIONER; FACILITATORS; BARRIERS; FIT;
D O I
10.1016/j.dld.2017.08.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The reasons for participation in fecal immunological testing (FIT) of subjects who were previously non-respondents to guaiac fecal occult blood testing (g-FOBT) have not been assessed. Population and methods: We aimed to determine the reasons for current compliance with FIT among non-responders to g-FOBT, termed "converts", in a French district. A questionnaire was returned by 170 converts aged from 55 to 75 years (response rate 75.2% after exclusions). Results: The major barriers to participation in screening with g-FOBT were test-related: the test was perceived as complicated (24%) and it required three consecutive stools (28%). Among the test-related major determinants of FIT compliance was the perception that the test was less complicated than previous test (30%) and that a unique stool sample was required (29%). Among the non-test related major determinants of FIT compliance were the perception that the general practitioner was more convincing (31%) and the feeling to be more concerned because of age (21%). The reasons for compliance among converts did not differ according to age, sex, and rural or urban residence. Conclusions: Our study demonstrated that the simplicity of FIT and the endorsement of practitioners were both major motivations for FIT compliance among non-respondents in at least two previous consecutive campaigns. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1267 / 1272
页数:6
相关论文
共 21 条
[1]  
[Anonymous], 2012, Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012
[2]   Efficacy of communication skills training on colorectal cancer screening by GPs: a cluster randomised controlled trial [J].
Aubin-Auger, I. ;
Laouenan, C. ;
Le Bel, J. ;
Mercier, A. ;
Baruch, D. ;
Lebeau, J. P. ;
Youssefian, A. ;
Le Trung, T. ;
Peremans, L. ;
Van Royen, P. .
EUROPEAN JOURNAL OF CANCER CARE, 2016, 25 (01) :18-26
[3]   Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust [J].
Chambers, Julie A. ;
Callander, Alana S. ;
Grangeret, Rebecca ;
O'Carroll, Ronan E. .
BMC CANCER, 2016, 16
[4]   What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): A qualitative study [J].
Chapple, Alison ;
Ziebland, Sue ;
Hewitson, Paul ;
McPherson, Ann .
SOCIAL SCIENCE & MEDICINE, 2008, 66 (12) :2425-2435
[5]   Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner [J].
Cole, SR ;
Young, GP ;
Byrne, D ;
Guy, JR ;
Morcom, J .
JOURNAL OF MEDICAL SCREENING, 2002, 9 (04) :147-152
[6]  
FAIVRE J, 1995, GASTROEN CLIN BIOL, V19, P361
[7]   Cancer screening barriers and facilitators for under and never screened populations: A mixed methods study [J].
Gesink, Dionne ;
Filsinger, Brooke ;
Mihic, Alanna ;
Norwood, Todd A. ;
Racey, C. Sarai ;
Perez, Daniel ;
Antal, Joan ;
Ritvo, Paul ;
Vernich, Lee .
CANCER EPIDEMIOLOGY, 2016, 45 :126-134
[8]   Colorectal cancer screening: Physician recommendation is influential advice to Marylanders [J].
Gilbert, A ;
Kanarek, N .
PREVENTIVE MEDICINE, 2005, 41 (02) :367-379
[9]  
Gordon NP, BMC PUBLIC HLTH, V15, P546
[10]   Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test [J].
Hassan, C. ;
Rossi, P. Giorgi ;
Camilloni, L. ;
Rex, D. K. ;
Jimenez-Cendales, B. ;
Ferroni, E. ;
Borgia, P. ;
Zullo, A. ;
Guasticchi, G. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (10) :929-940